The price of NPS Pharmaceuticals shares has slipped to $7.48 (a 0.8% change) on heavy trading volume. Approximately 1.6 million shares have changed hands today vs. average 30-day volume of 1.3 million shares. Spikes in volume can validate a breakout or signify a potential turning point.
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.
Over the past year, NPS Pharmaceuticals has traded in a range of $6.30 to $11.22 and is now at $7.48, 19% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 1.3%.
NPS Pharmaceuticals (NASDAQ:NPSP) has potential upside of 120.0% based on a current price of $7.48 and analysts' consensus price target of $16.45. The stock should run into initial resistance at its 200-day moving average (MA) of $8.55 and subsequent resistance at its 50-day MA of $8.83.